Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Hematology · Zhujiang Hospital · Guangzhou

Dr. Tu Sanfang涂三芳

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

TS

Professional overview

Dr. Tu Sanfang is a Chief Physician in the Department of Hematology at Zhujiang Hospital, specializing in the diagnosis and treatment of malignant hematologic diseases.

SpecialtyHematology
Clinical titleChief Physician
Academic rolesLecturer, Master's Supervisor
DepartmentDepartment of Hematology
HospitalZhujiang Hospital
CityGuangzhou

Areas of focus

CAR-T cell immunotherapyA cellular immunotherapy approach used in treating malignant hematologic diseases.
hematopoietic stem cell transplantationA transplantation modality used in treating malignant hematologic diseases.
pathogenesis of graft-versus-host diseaseResearch focus on the mechanisms underlying graft-versus-host disease.

Experience & recognition

  • More than 10 years of clinical and research experience in hematologic diseases
  • Published over 10 SCI research papers
  • Principal or co-investigator on multiple national and provincial research projects

Professional roles

  • Youth Committee Member, Professional Committee of Precision Diagnosis and Treatment of Hematologic Diseases, Chinese Research Hospital Association
  • Standing Committee Member, Lymphoma Professional Committee, Guangdong Provincial Association of Female Physicians
  • Standing Committee Member, Hematology Professional Committee, Guangdong Provincial Association of Female Physicians
  • Member, Lymphoma Professional Committee, Guangdong Anti-Cancer Association
  • Member, Hematologic Immunology Professional Committee, Guangdong Provincial Immunological Society

Frequently asked questions

What does Dr. Tu Sanfang specialize in?

Specializes in diagnosis and treatment of malignant hematologic diseases, especially CAR-T cell immunotherapy and hematopoietic stem cell transplantation; research focuses on cellular immunotherapy for malignant hematologic diseases and pathogenesis of graft-versus-host disease.

Which hospital and department is Dr. Tu Sanfang in?

Department of Hematology at Zhujiang Hospital

Sources

Dr. Tu Sanfang has not reviewed this page.